207 related articles for article (PubMed ID: 21303696)
1. Ndrg1 in development and maintenance of the myelin sheath.
King RH; Chandler D; Lopaticki S; Huang D; Blake J; Muddle JR; Kilpatrick T; Nourallah M; Miyata T; Okuda T; Carter KW; Hunter M; Angelicheva D; Morahan G; Kalaydjieva L
Neurobiol Dis; 2011 Jun; 42(3):368-80. PubMed ID: 21303696
[TBL] [Abstract][Full Text] [Related]
2. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves.
Okuda T; Higashi Y; Kokame K; Tanaka C; Kondoh H; Miyata T
Mol Cell Biol; 2004 May; 24(9):3949-56. PubMed ID: 15082788
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of the N-Myc downstream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom.
Berger P; Sirkowski EE; Scherer SS; Suter U
Neurobiol Dis; 2004 Nov; 17(2):290-9. PubMed ID: 15474366
[TBL] [Abstract][Full Text] [Related]
4. CMT4D (NDRG1 mutation): genotype-phenotype correlations.
Ricard E; Mathis S; Magdelaine C; Delisle MB; Magy L; Funalot B; Vallat JM
J Peripher Nerv Syst; 2013 Sep; 18(3):261-5. PubMed ID: 24028195
[TBL] [Abstract][Full Text] [Related]
5. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement.
Echaniz-Laguna A; Degos B; Bonnet C; Latour P; Hamadouche T; Lévy N; Leheup B
Neuromuscul Disord; 2007 Feb; 17(2):163-8. PubMed ID: 17142040
[TBL] [Abstract][Full Text] [Related]
6. N-myc downstream-regulated gene 1 expression in injured sciatic nerves.
Hirata K; Masuda K; Morikawa W; He JW; Kuraoka A; Kuwano M; Kawabuchi M
Glia; 2004 Sep; 47(4):325-34. PubMed ID: 15293230
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
8. NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.
Hunter M; Angelicheva D; Tournev I; Ingley E; Chan DC; Watts GF; Kremensky I; Kalaydjieva L
Biochem Biophys Res Commun; 2005 Jul; 332(4):982-92. PubMed ID: 15922294
[TBL] [Abstract][Full Text] [Related]
9. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
Berger P; Niemann A; Suter U
Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
[TBL] [Abstract][Full Text] [Related]
10. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.
Jiang LT; Chen YH; Huang JH; Tong WF; Jin LJ; Li LX
Mol Cell Biol; 2022 Jul; 42(7):e0055921. PubMed ID: 35708320
[TBL] [Abstract][Full Text] [Related]
12. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D.
Li LX; Liu GL; Liu ZJ; Lu C; Wu ZY
Hum Mutat; 2017 Nov; 38(11):1569-1578. PubMed ID: 28776325
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model.
ten Asbroek AL; Verhamme C; van Groenigen M; Wolterman R; de Kok-Nazaruk MM; Baas F
J Neurosci Res; 2005 Mar; 79(6):825-35. PubMed ID: 15672449
[TBL] [Abstract][Full Text] [Related]
15. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy.
Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I
J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells.
Chojnowski A; Ravisé N; Bachelin C; Depienne C; Ruberg M; Brugg B; Laporte J; Baron-Van Evercooren A; LeGuern E
Neurobiol Dis; 2007 May; 26(2):323-31. PubMed ID: 17336078
[TBL] [Abstract][Full Text] [Related]
18. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
19. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
[TBL] [Abstract][Full Text] [Related]
20. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells.
Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():281-93. PubMed ID: 10586253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
